These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38731190)

  • 1. The Application of a Synthetic Biodegradable Temporizing Matrix in Extensive Burn Injury: A Unicenter Experience of 175 Cases.
    Tapking C; Panayi AC; Hundeshagen G; Thomas BF; Gazyakan E; Bliesener B; Bigdeli AK; Kneser U; Vollbach FH
    J Clin Med; 2024 May; 13(9):. PubMed ID: 38731190
    [No Abstract]   [Full Text] [Related]  

  • 2. NovoSorb® Biodegradable Temporising Matrix (BTM): What we learned from the first 300 consecutive cases.
    Tapking C; Thomas BF; Hundeshagen G; Haug VFM; Gazyakan E; Bliesener B; Bigdeli AK; Kneser U; Vollbach FH
    J Plast Reconstr Aesthet Surg; 2024 May; 92():190-197. PubMed ID: 38547552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of Biodegradable Temporizing Matrix application for complex wound reconstruction.
    Grande PK; Hill D; McElfresh J; Velamuri R; Liu X
    J Burn Care Res; 2024 May; ():. PubMed ID: 38733573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of NovoSorb biodegradable temporising matrix in wound management: a literature review and case series.
    Kidd T; Kolaityte V; Bajaj K; Wallace D; Izadi D; Bechar J
    J Wound Care; 2023 Aug; 32(8):470-478. PubMed ID: 37572341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NovoSorb® Biodegradable Temporizing Matrix: a novel approach for treatment of extremity avulsion injuries in children.
    Najem S; Fattouh M; Wintges K; Schoof B; Koerner M; Reinshagen K; Koenigs I
    Eur J Trauma Emerg Surg; 2024 Aug; 50(4):1807-1815. PubMed ID: 38668874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wound healing and dermal regeneration in severe burn patients treated with NovoSorb® Biodegradable Temporising Matrix: A prospective clinical study.
    Lo CH; Brown JN; Dantzer EJG; Maitz PKM; Vandervord JG; Wagstaff MJD; Barker TM; Cleland H
    Burns; 2022 May; 48(3):529-538. PubMed ID: 34407914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and Neck Wound Reconstruction Using Biodegradable Temporizing Matrix Versus Collagen-Chondroitin Silicone Bilayer.
    Wu SS; Wells M; Ascha M; Duggal R; Gatherwright J; Chepla K
    Eplasty; 2022; 22():e31. PubMed ID: 36000010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper Extremity Wounds Treated with Biodegradable Temporizing Matrix versus Collagen-Chondroitin Silicone Bilayer.
    Wu SS; Wells M; Ascha M; Gatherwright J; Chepla KJ
    J Hand Microsurg; 2023 Dec; 15(5):340-350. PubMed ID: 38152680
    [No Abstract]   [Full Text] [Related]  

  • 9. Reconstruction of Extensive Calvarial Exposure After Major Burn Injury in 2 Stages Using a Biodegradable Polyurethane Matrix.
    Greenwood JE; Wagstaff MJ; Rooke M; Caplash Y
    Eplasty; 2016; 16():e17. PubMed ID: 27222681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyaderm(®) dermal substitute: clinical application and long-term results in 55 patients.
    Pirayesh A; Hoeksema H; Richters C; Verbelen J; Monstrey S
    Burns; 2015 Feb; 41(1):132-44. PubMed ID: 24946965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Analysis of Animal-Derived vs Fully Synthetic Acellular Dermal Matrices in Reconstructive Surgery: An Examination of Clinical, Aesthetic, and Economic Measures.
    Olsen T; Ali-Khan S; Bell D
    Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S172-S178. PubMed ID: 38556669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the modified meek technique for the coverage of extensive burn wounds.
    Tapking C; Panayi A; Haug V; Palackic A; Houschyar KS; Claes KEY; Kuepper S; Vollbach F; Kneser U; Hundeshagen G
    Burns; 2024 May; 50(4):1003-1010. PubMed ID: 38383170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting success of split-thickness skin grafts in the modern burn unit.
    Thourani VH; Ingram WL; Feliciano DV
    J Trauma; 2003 Mar; 54(3):562-8. PubMed ID: 12634539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term scarring outcomes and safety of patients treated with NovoSorb
    Lo CH; Wagstaff MJD; Barker TM; Damkat-Thomas L; Salerno S; Holden D; Concannon E; Heath K; Coghlan P; Cleland H
    JPRAS Open; 2023 Sep; 37():42-51. PubMed ID: 37360978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and resource utilisation in patients with major burns treated with NovoSorb® BTM.
    Betar N; Maher D; Wheatley L; Barker T; Brown J
    Burns; 2023 Nov; 49(7):1663-1669. PubMed ID: 37344307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable temporising matrix: use of negative pressure wound therapy shows a significantly higher success rate.
    Austin CL; Draper B; Larson KW; Thompson SJ
    J Wound Care; 2023 Mar; 32(3):159-166. PubMed ID: 36930194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with NovoSorb® Biodegradable Temporising Matrix in reconstruction of complex wounds.
    Li H; Lim P; Stanley E; Lee G; Lin S; Neoh D; Liew J; Ng SK
    ANZ J Surg; 2021 Sep; 91(9):1744-1750. PubMed ID: 34085755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novosorb® Biodegradable Temporising Matrix (BTM) and its Applications.
    Lim P; Li H; Ng S
    Surg Technol Int; 2023 Apr; 42():. PubMed ID: 37053370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of a method for repairing extremities with extensively deep burn using fresh allogeneic scalp and autologous microskin and observation of its effect].
    Cai JH; Shen ZA; Sun TJ; Li DJ; Deng HP; Li DW; Liu ZX; Wang L; He LX
    Zhonghua Shao Shang Za Zhi; 2019 Apr; 35(4):253-260. PubMed ID: 31060172
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.